Kelly Kaihara, PhD is currently working as a Director at General Inception, where Kelly leads Life Science Tools & Diagnostics Investments. Kelly also mentors at Nucleate and serves as an Advisory Board Member at Nucleic Sensing Systems. Kelly is a Mentor and Judge at BioTools Innovator, an Advisor at Partillion Bioscience, and has previous experience as a Fractional Executive at Switchback Systems. Kelly has a background in market development, field application science, and postdoctoral research in biotech and life sciences. Kelly holds a Ph.D. in Biomedical Sciences from the University of Chicago and has diverse educational experiences at Carleton College, UC Berkeley, and UC San Francisco.
April, 2021 - present